Peer-reviewed Publications

  • Chung HC, Cho JE, Lee H, Kim WK, Oh JH, Kim SH, Lee D, Sung CO. Integrated single-cell RNA sequencing analyses suggest developmental paths of cancer-associated fibroblasts with gene expression dynamics. Clinical and Translational Medicine. 2021;11:e487. (IF: 11.492)

  • Kim S, Ahn JM, Bae WJ, Han JH, Lee D. Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer. Gastric Cancer. 2021;24(3):577-588. (IF: 7.37)

  • Kim S, Bae WJ, Ahn JM, Heo JH, Kim KM, Choi KW, Sung CO, Lee D. MicroRNA signatures associated with lymph node metastasis in intramucosal gastric cancer. Modern Pathology. 2021;34(3):672-683. (IF: 7.842)

  • Kim S, Kim N, Lee J, Kim S, Hong J, Son S, Do Heo W. Dynamic Fas signaling network regulates neural stem cell proliferation and memory enhancement. Science Advances. 2021;22(6):eaaz9691. (IF: 14.136)

  • Kim S, Shin J, Oh H, Ahn S, Kim N, Heo WD. An inducible system for in vitro and in vivo Fas activation using FKBP-FRB-rapamycin complex. Biochem Biophys Res Communications. 2020;523(2):473-480. (IF: 3.575)

  • Kim YS, Noh HJ, Yoo I, Lee D. Androgen receptor is mostly not expressed in gastric cancers. Applied Immunohistochemistry & Molecular Morphology. 2020;28(2):e17-18. (IF: 2.085)

  • Bae WJ, Ahn JM, Byeon HE, Kim S, Lee D. PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin. Journal of Experimental and Clinical Cancer Research. 2019;38(1):484. (IF: 11.161)

  • Ham IH, Oh HJ, Jin H, Bae CA, Jeon SM, Choi KS, Son SY, Han SU, Brekken RA, Lee D. Hur H. Targeting interleukin-6 as a strategy to overcome stroma-induced strategy to chemotherapy in gastric cancer. Molecular Cancer. 2019;18(1):68. (IF: 27.401)

  • Kim YB, Ahn JM, Bae WJ, Sung CO, Lee D. Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer. International Journal of Cancer. 2019;145(4):916-926. (IF: 7.369)

  • Choi JH, Kim YB, Ahn JM, Kim MJ, Bae WJ, Han SU, Woo HG, Lee D. Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer. Experimental & Molecular Medicine. 2018;50(4):1-11. (IF: 8.718)

  • Lee D, Son SY, Kim YB, Han SU, Hur H. Neural invasion is a significant contributor to peritoneal recurrence in signet ring cell gastric carcinoma. Ann Surg Oncol. 2018;25(5):1167-1175. (IF: 5.344)

  • Lee D, Han IH, Son SY, Han SU, Kim YB, Hur H. Intratumor stromal proportion predicts aggressive phenotype of gastric signet ring cell carcinomas. Gastric Cancer. 2017;20(4):591-601. (IF: 7.37)

  • Lee D, Yu EJ, Ham IH, Hur H, Kim YS. AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells. OncoTargets and Therapy. 2017;10:4153-4159. (IF: 4.147)

  • Kim YB, Han SU, Lee D. Prominent neural invasion of mucosal gastric cancer into the muscularis propria. Histopathology. 2017;71(4):661-662. (IF: 5.087)